Patent
   D434136
Priority
Apr 07 1998
Filed
Feb 23 1999
Issued
Nov 21 2000
Expiry
Nov 21 2014
Assg.orig
Entity
unknown
4
7
n/a
The ornamental design for a pharmaceutical tablet, as shown and described.

FIG. 1 is a top perspective view of a pharmaceutical tablet showing the new design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a side elevational view thereof;

FIG. 4 is an end elevational view thereof;

FIG. 5 is a bottom plan view thereof;

FIG. 6 is a side elevational view thereof, opposite of FIG. 3; and,

FIG. 7 is an end elevational view thereof, opposite of FIG. 4.

The horizontal line shading in the upper right corner of the article of FIG. 1 is understood to represent the color blue and extend to cover all surfaces of the claimed design.

Burrows, Robert

Patent Priority Assignee Title
10350296, Jul 22 2013 Aspire Pharmaceuticals Chewable gelatin formulations
D508992, May 05 2004 Access Business Group International LLC Dietary supplement
D726899, Jul 22 2013 ASPIRE PHARMACEUTICALS, INC Chewable dosage form
D907760, Jan 20 2017 SOCIÉTÉ DES PRODUITS NESTLÉ S A Orally ingestible tablet
Patent Priority Assignee Title
3125490,
D283739, Jul 02 1984 Smith Kline & French Laboratories Limited Pharmaceutical tablet
D302051, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D302337, Mar 11 1987 Boots Company PLC Pharmaceutical tablet
D304626, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D377086, Jul 28 1995 McNeil-PPC, Inc Tablet
D383533, Mar 12 1996 GlaxoSmithKline LLC Pharmaceutical tablet
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Feb 23 1999Pfizer Inc(assignment on the face of the patent)
Jun 19 2000BURROWS, ROBERTPfizer IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0109630292 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule